Annual report pursuant to Section 13 and 15(d)

Schedule of Capitalized Technology (Details)

v3.22.1
Schedule of Capitalized Technology (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Research and Development [Abstract]    
Balance, beginning of period $ 25,867 $ 95,884
Additional capitalized cost 49,970 3,700
Provision for amortization (32,799) (73,717)
Balance, end of period $ 43,038 $ 25,867